Sector Watch: Healthcare - Sep 20 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $119.29 +1.63 1.39% | XBI: $97.16 +1.59 1.66% | Updated Sep 20, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| CRBP Corbus Pharmaceuticals Holdings $454.8M |
7.95+2.77 17.9 M 41.0x |
54% | ||
| ACAD ACADIA Pharmaceuticals $2.4B |
19.11+4.01 15.0 M 7.2x |
27% | ||
| CNAT Conatus Pharmaceuticals $167.2M |
5.54+0.82 1.5 M 3.1x |
17% | ||
| GALT Galectin Therapeutics $283.5M |
6.93+0.88 2.3 M 2.8x |
15% | ||
| LCI Lannett Co Inc $214.0M |
5.50+0.65 1.7 M |
13% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| OMED OncoMed Pharmaceuticals $92.4M |
2.40-0.40 270.3 K 3.8x |
-14% | ||
| RIGL Rigel Pharmaceuticals $552.6M |
3.32-0.27 5.6 M 2.0x |
-8% | ||
| AFMD Affimed $271.4M |
4.35-0.35 1.6 M |
-7% | ||
| CVM Cel-Sci $83.6M |
3.55-0.23 1.1 M |
-6% | ||
| KMPH KemPharm $75.0M |
4.68-0.27 150.3 K 2.3x |
-6% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
OncoMed Provides Update on Navicixizumab Partnership [globenewswire.com]Galectin Therapeutics, Inc. Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA® in Advanced Melanoma and Expansion of the Trial [globenewswire.com]
Conatus Pharmaceuticals to Host Analyst and Investor Symposium on Portal Hypertension [globenewswire.com]
Corbus Pharmaceuticals Expands Target Indications by Adding More Than 600 Compounds Focused on the Endocannabinoid System from Jenrin Discovery; Includes CRB-4001 with Planned NIH-Supported Phase 2 Study [globenewswire.com]
Conatus Pharmaceuticals to Participate in Upcoming Investor Conferences [globenewswire.com]
Corbus Pharmaceuticals Receives Orphan Designation for Lenabasum for the Treatment of Dermatomyositis in the European Union [globenewswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, FIZZ, RMTI, TTPH and FB [globenewswire.com]
KemPharm Announces Positive Topline Results from Intranasal Human Abuse Potential Trial of KP415 Prodrug [globenewswire.com]
ACADIA PHARMACEUTICALS 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD | Business Wire [businesswire.com]
CLASS ACTION UPDATE -- DEADLINE MONDAY for ACAD and FIZZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
ACADIA PHARMA 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD | Business Wire [businesswire.com]
CEL-SCI Receives $5.4 Million from Warrant Exercises | Business Wire [businesswire.com]
Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2018 ACR Annual Meeting [globenewswire.com]
Depression - Pipeline Review, H2 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
Investors: The Law Offices of Howard G. Smith Reminds Investors of Lead Plaintiff Deadline in the Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. (ACAD) [globenewswire.com]
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National Beverage, ACADIA, and Vuzix and Encourages Investors to Contact the Firm [globenewswire.com]
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm | Business Wire [businesswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LCI, ACAD and FB [globenewswire.com]
KESSLER TOPAZ MELTZER & CHECK, LLP: Final Deadline Reminder for ACADIA PHARMACEUTICALS INC. Investors ? ACAD [globenewswire.com]
Investors: The Law Offices of Howard G. Smith Reminds Investors of Lead Plaintiff Deadline in the Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. (ACAD) | Business Wire [businesswire.com]
CLASS ACTION UPDATE for ACAD and FB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
